|Articles|June 1, 2003
Mycosis Fungoides
San Francisco - When it comes to determining the prognosis of mycosis fungoides, age and disease stage at presentation are particularly important, according to Rosamaria Corona, D.Sc., M.D., a dermatologist and epidemiologist at the Istituto Dermopatico dell'Immacolata (IDI) in Rome.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Phase 2 Nemolizumab Trial Opens for CPUO
5














